Vis enkel innførsel

dc.contributor.authorMc Tiernan, Nina
dc.contributor.authorDarbakk, Christine
dc.contributor.authorRee, Rasmus
dc.contributor.authorArnesen, Thomas
dc.date.accessioned2021-07-09T07:34:28Z
dc.date.available2021-07-09T07:34:28Z
dc.date.created2021-01-17T21:15:17Z
dc.date.issued2020
dc.identifier.issn1422-0067
dc.identifier.urihttps://hdl.handle.net/11250/2763997
dc.description.abstractThe majority of the human proteome is subjected to N-terminal (Nt) acetylation catalysed by N-terminal acetyltransferases (NATs). The NatA complex is composed of two core subunits—the catalytic subunit NAA10 and the ribosomal anchor NAA15. Furthermore, NAA10 may also have catalytic and non-catalytic roles independent of NatA. Several inherited and de novo NAA10 variants have been associated with genetic disease in humans. In this study, we present a functional analysis of two de novo NAA10 variants, c.29A>G p.(D10G) and c.32T>G p.(L11R), previously identified in a male and a female, respectively. Both of these neighbouring amino acids are highly conserved in NAA10. Immunoprecipitation experiments revealed that both variants hamper complex formation with NAA15 and are thus likely to impair NatA-mediated Nt-acetylation in vivo. Despite their common impact on NatA formation, in vitro Nt-acetylation assays showed that the variants had opposing impacts on NAA10 catalytic activity. While NAA10 c.29A>G p.(D10G) exhibits normal intrinsic NatA activity and reduced monomeric NAA10 NAT activity, NAA10 c.32T>G p.(L11R) displays reduced NatA activity and normal NAA10 NAT activity. This study expands the scope of research into the functional consequences of NAA10 variants and underlines the importance of understanding the diverse cellular roles of NAA10 in disease mechanisms.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleNAA10 p.(D10G) and NAA10 p.(L11R) variants hamper formation of the NatA N-terminal acetyltransferase complexen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright the authorsen_US
dc.source.articlenumber8973en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3390/ijms21238973
dc.identifier.cristin1872730
dc.source.journalInternational Journal of Molecular Sciencesen_US
dc.relation.projectHelse Vest RHF: F-12540-D11382en_US
dc.relation.projectKreftforeningen: 171752—PR-2009-0222en_US
dc.relation.projectHelse Vest RHF: 912176en_US
dc.relation.projectNorges forskningsråd: 249843en_US
dc.identifier.citationInternational Journal of Molecular Sciences. 2020, 21 (23), 8973.en_US
dc.source.volume21en_US
dc.source.issue23en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal